Cytokinetics Inc (NAS:CYTK)
$ 48.3 -0.68 (-1.39%) Market Cap: 5.06 Bil Enterprise Value: 5.20 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 43/100

Cytokinetics Inc Annual Shareholders Meeting Transcript

May 15, 2019 / 05:30PM GMT
Release Date Price: $10.68 (+2.40%)
Operator

Good morning, and welcome, ladies and gentlemen, to the Cytokinetics 2019 Annual Stockholders Meeting. At this time, I would like to inform you that this meeting is being recorded. (Operator Instructions)

I will now turn the meeting over to Pat Gage, the Chairman of Cytokinetics Board of Directors. Please go ahead.

Leonard Patrick Gage
Cytokinetics, Incorporated - Chairman

Good morning, everyone. My name is Patrick Gage, and I am the Chairman of the Board of Directors of Cytokinetics. It's my pleasure to welcome you to the 2019 Annual Meeting of Stockholders.

Meeting is now called to order. I've asked Mark Schlossberg, our Senior Vice President and General Counsel and Corporate Secretary, to record the minutes. Before proceeding to the formal business, I will introduce the members of the Cytokinetics Board of Directors and management who are here with us today.

Robert Blum, who's our President and Chief Executive Officer, and will also provide us with a overview of the company and our plans for 2019 after our formal meeting.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot